Akebia Therapeutics
AKBA • NASDAQ
Akebia Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Butler, with a market cap of $377.7M.
Market Cap$377.7M
Employees167.0
CEOJohn Butler
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Akebia Therapeutics FAQ
Common questions about Akebia Therapeutics
Akebia Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $53.0M.
Akebia Therapeutics has approximately 167 employees.